ClinicalTrials.gg
CompletedNCT05419687VIA-HUpdated Jan 22, 2025

Violence Against Health Care Workers in Fragile Settings

An interventional study of Training in de-escalating violence and Code of conduct delivered via a warning board in Workplace Violence, sponsored by Swiss Tropical & Public Health Institute. Completed at 2 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-22.

Sponsored by Swiss Tropical & Public Health Institute · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
798
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The general objective of the project is to assess whether a violence de-escalating training for health professionals and of a publicly displayed Code of Conduct (a set of rules developed through a citizen science and co-design approach) for both health professionals and clients at the level of the health facility, can reduce the incidence and severity of episodes of violence, and to identify the most cost-effective way to implement these interventions in rural Democratic Republic of Congo (DRC) and in the mega city of Baghdad, Iraq.

Read the detailed description

The study will adopt a stepped-wedge cluster-randomized intervention trial (SW-CRT) design to assess the two intervention components, a violence de-escalating training and the implementation of the code of conduct co-developed during the formative qualitative phase. The study will adopt a closed cohort with repeated measurements on the same participants (nurses in DRC and junior doctors in Baghdad) and will involve the unidirectional transition of each enrolled cluster (health facilities in DRC and secondary hospitals in Baghdad) from the control (no intervention) to the intervention sequence in a randomized sequential manner according to a predefined roll out process.

02

Conditions studied

  • Workplace Violence

Browse trials for

Keywords

  • de-escalating
  • violence prevention
  • behavioral symptoms
  • code of conduct
03

In context

Behavioral Symptoms

135 studies on the registry are indexed under Behavioral Symptoms; 18 are open to participants now.

This study's enrollment of 798 is above the median of 93 across 114 interventional studies indexed under Behavioral Symptoms.

Browse Behavioral Symptoms studies →

Lead sponsor

Swiss Tropical & Public Health Institute is the lead sponsor of 58 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • HCWs from selected participating health facilities in DRC, junior doctors during their first year resident and permanent health care staff from participating secondary hospitals in Iraq
  • HCWs and junior medical doctors and permanent health care staff must have been employed/ or worked as HCW/ medical doctors or as permanent health care staff for at least 6 months
  • All above participants must have completed the written

Exclusion criteria

Exclusion Criteria:

  • Age \<18 years; cognitive impairment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
798 participants (actual)

Study arms

  • Experimental
    Arm 1 De-escalating violence training

    The de-escalating violence training intervention will be introduced after a pre-interventional period of 3 months. A refreshment training will be introduced at month 11.

    Behavioral: Training in de-escalating violence

  • Experimental
    Arm 2 De-escalating violence training

    The de-escalating violence training intervention will be introduced before the second observation period at month 11. A refreshment training will be introduced at month 18.

    Behavioral: Training in de-escalating violence

  • Experimental
    Arm 3 De-escalating violence training

    The de-escalating violence training intervention will be introduced before the third observation period at month 18.

    Behavioral: Training in de-escalating violence

  • Experimental
    Arm 4 De-escalating violence training + Code of conduct

    The de-escalating violence training intervention will be introduced after a pre-interventional period of 3 months. The code of conduct via a warning board will be introduced at month 11. A refreshment training will be introduced at month 18.

    Behavioral: Training in de-escalating violence · Behavioral: Code of conduct delivered via a warning board

  • Experimental
    Arm 5 De-escalating violence training + Code of conduct

    The de-escalating violence training intervention and the code of conduct via a warning board will be simultaneously introduced at month 11. A refreshment training will be introduced at month 18.

    Behavioral: Training in de-escalating violence · Behavioral: Code of conduct delivered via a warning board

  • Experimental
    Arm 6 Code of conduct + De-escalating violence training

    The code of conduct via a warning board will be introduced at month 11. The de-escalating violence training intervention will be introduced at month 18.

    Behavioral: Training in de-escalating violence · Behavioral: Code of conduct delivered via a warning board

  • Experimental
    Arm 7 De-escalating violence training + Code of conduct

    The de-escalating violence training intervention is introduced after a pre-interventional period of 3 months. The code of conduct via a warning board and a refreshment training will be simultaneously introduced at month 18.

    Behavioral: Training in de-escalating violence · Behavioral: Code of conduct delivered via a warning board

  • Experimental
    Arm 8 De-escalating violence training + Code of conduct

    The de-escalating violence training intervention will be introduced before the second observation period at month 11. The code of conduct via a warning board and a refreshment training will be simultaneously introduced at month 18.

    Behavioral: Training in de-escalating violence · Behavioral: Code of conduct delivered via a warning board

  • Experimental
    Arm 9 De-escalating violence training + Code of conduct

    The code of conduct via a warning board and the violence de-escalating training will be simultaneously introduced at month 18.

    Behavioral: Training in de-escalating violence · Behavioral: Code of conduct delivered via a warning board

  • Experimental
    Arm 10 Code of conduct

    The code of conduct via a warning board will be introduced at month 11.

    Behavioral: Code of conduct delivered via a warning board

  • Experimental
    Arm 11 Code of conduct

    The code of conduct via a warning board will be introduced at month 18.

    Behavioral: Code of conduct delivered via a warning board

Interventions

  • BehavioralTraining in de-escalating violence

    * Individual educational component through a de-escalating violence training for health care workers (verbal and non-verbal de-escalating techniques) * Refreshment training in the form of collaborative learning

  • BehavioralCode of conduct delivered via a warning board

    A publicly displayed code of conduct (a co-designed set of rules) for both HCWs and clients, delivered via a warning board at the level of the health facilities and secondary hospitals

06

What researchers measure

Primary outcomes

  1. Incidence and severity of self-reported non-physical aggression

    Number of self-reported non-physical aggression (verbal abuse, threats, ironic language, provocative or aggressive body language etc.) during the fulfillment of a professional activity in the last 6 months

    Time frame: 6 months

  2. Incidence and severity of self-reported physical aggression

    Number of self-reported physical aggression during the fulfillment of a professional activity in the last 6 months

    Time frame: 6 months

Secondary outcomes

  1. Level of confidence in coping with patient aggression

    Instrument "Clinicians confidence in coping with patient aggression (CCPAI) (Thackreys, 1987)"

    Time frame: 0, 6, 12, 18 months

  2. Level of post-traumatic stress disorders (PTSD) among HCWs

    Instrument "Post-traumatic stress disorder PTSD Checklist for DSM-5 (PCL-5)) (Weathers, F.W. et al. 2013)"

    Time frame: 0, 6, 12, 18 months

  3. Level of burnout among HCWs

    Instrument "Level of burnout" (Malach 2005), burnout measure short version (BMS). The ten-item version of the BMS are evaluated on 7-point frequency scales, with a score of 4 or above indicating burnout.

    Time frame: 0, 6, 12, 18 months

  4. Psychological empathy among HCWs

    Instrument "Jefferson scale of physician empathy (Hojat M et al. 2007)"

    Time frame: 0, 6, 12, 18 months

  5. Absenteeism

    Number of sick leave spells taken by the HCWs during the study period

    Time frame: 0, 6, 12, 18 months

  6. Intent to leave among HCWs

    The shortened, six-item version of the turnover intention scale (TIS-6) (Bothma \& Roodt 2013), will be used to assess turnover intentions and as well as to predict actual turnover among HCWs. The TIS-6 scale is scored on a five-point Likert-type scale with scores ranging from 1 (never) to 5 ( always). A high score indicates stronger turnover intention.

    Time frame: 0, 6, 12, 18 months

  7. Economic cost of the intervention

    Two types of costs will be considered: 1) direct costs of the intervention (e.g training costs, space or rent costs, costs to develop the code of conduct) and 2) direct costs due to health system disruption (e.g. health care services foregone or postponed, material etc.), cost incurred by the HCWs as a consequence of violent episodes including direct medical costs (e.g. hospital stay cost, consultation costs, laboratory costs), non-medical costs (e.g. transportation, meals etc.), and indirect costs (e.g. absenteeism, presenteeism).

    Time frame: 18 months

  8. Productivity loss (presenteeism)

    Work Limitation questionnaire (WLQ) (Lerner D. et al. 2002). The WLQ consists of eight items investigating four domains (time management, physical tasks, mental-interpersonal tasks, and output tasks), which are calculated into scores ranging from 0 (no limitations) to 100 (highest limitations).

    Time frame: 18 months

  9. Health care workers health-related quality of life

    European Quality of Life-5 Dimensions (EuroQol EQ-5D-5L) (Devlin NJ et al. 2017). The EQ-5D-5L questionnaire is self-assessed and it measures health outcomes on five dimensions (mobility, self-care, daily activities, pain/discomfort, and depression/anxiety) with five levels ranging from none to major complaints. Scores range from 0 (death) to 1 (full health).

    Time frame: 0, 6, 12, 18 months

07

Study locations

2 sites
  • Catholic University of Bukavu, School of Public Health
    Bukavu, Democratic Republic of the Congo
  • Al-Mustansiriya University
    Baghdad, Iraq
08

References and documents

Publications

  • Elrha, International Committee of the Red Cross (ICRC), RAND Europe. Researching Violence Against Health Care: Gaps and Priorities. 2020
  • Leach, Brandi, Emily Ryen Gloinson, Alex Sutherland, and Michael Whitmore, Reviewing the Evidence Base for De-escalation Training: A Rapid Evidence Assessment. Santa Monica, CA: RAND Corporation, 2019.
  • Geoffrion S, Hills DJ, Ross HM, Pich J, Hill AT, Dalsbo TK, Riahi S, Martinez-Jarreta B, Guay S. Education and training for preventing and minimizing workplace aggression directed toward healthcare workers. Cochrane Database Syst Rev. 2020 Sep 8;9(9):CD011860. doi: 10.1002/14651858.CD011860.pub2. PubMed 32898304 ↗
  • Ferrari G, Lwamushi SM, Balaluka GB, Lafta RK, Schindler C, Bugugu D, Lurhangire E, Tediosi F, Mendoza JR, Merten S. Understanding context of violence against healthcare through citizen science and evaluating the effectiveness of a co-designed code of conduct and of a tailored de-escalation of violence training in Eastern Democratic Republic of Congo and Iraq: a study protocol for a stepped wedge randomized controlled trial. Trials. 2023 Dec 19;24(1):814. doi: 10.1186/s13063-023-07839-3. PubMed 38110997 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2022 to primary completion in Oct 2024, 23 months.

Of 68 non-industry interventional studies with no phase under Behavioral Symptoms, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 55. This study's 23 months is below that.

Counting every sponsor, half of 68 studies reached it within 27 months; a quarter within 16 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2022
First posted
Jun 15, 2022
StartActual
Nov 1, 2022
Primary completionActual
Oct 31, 2024
CompletionActual
Oct 31, 2024
Last update
Jan 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05419687
Lead sponsor
Swiss Tropical & Public Health Institute
Collaborators
International Committee of the Red Cross (ICRC), Catholic University of Bukavu, Democratic Republic of Congo, Al-Mustansiriyah University
Responsible party
Sponsor
First posted
Jun 15, 2022
Start date
Nov 1, 2022
Primary completion
Oct 31, 2024
Completion
Oct 31, 2024
Last update
Jan 22, 2025

Study contacts

Sonja Merten, MD MPH PhD
principal investigator · Swiss Tropical and Public Health Institute (Swiss TPH)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion